ArticleScientific reports2019

Aberrant Regulation of RAD51 Promotes Resistance of Neoadjuvant Endocrine Therapy in ER-positive Breast Cancer.

Yan Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.